Compare Stocks: CERS, XRAY, AVNS, and QDEL

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AVNS Avanos Medical	$24.99	$24.99	$9.30 ▼ $25.49	$1.17B	1.57	700,357 shs	N/A
CERS Cerus	$2.34 +2.6%	$2.58	$1.38 ▼ $3.47	$459.48M	1.83	1.72 million shs	1.84 million shs
QDEL QuidelOrtho	$12.14 +12.7%	$13.46	$9.92 ▼ $35.58	$738.56M	0.79	1.52 million shs	2.69 million shs
XRAY DENTSPLY SIRONA	$8.56 -1.3%	$11.01	$8.44 ▼ $14.76	$1.73B	0.87	4.84 million shs	5.01 million shs

7 Stocks That Will Be Magnificent in 2026

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AVNS Avanos Medical	0.00%	0.00%	0.00%	+0.26%	+111.33%
CERS Cerus	+2.63%	-4.49%	-9.65%	-27.33%	+49.04%
QDEL QuidelOrtho	+12.72%	+12.10%	-13.10%	-28.59%	-59.51%
XRAY DENTSPLY SIRONA	-1.27%	-7.76%	-24.78%	-29.78%	-35.10%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AVNS Avanos Medical	$24.99	$24.99	$9.30 ▼ $25.49	$1.17B	1.57	700,357 shs	N/A
CERS Cerus	$2.34 +2.6%	$2.58	$1.38 ▼ $3.47	$459.48M	1.83	1.72 million shs	1.84 million shs
QDEL QuidelOrtho	$12.14 +12.7%	$13.46	$9.92 ▼ $35.58	$738.56M	0.79	1.52 million shs	2.69 million shs
XRAY DENTSPLY SIRONA	$8.56 -1.3%	$11.01	$8.44 ▼ $14.76	$1.73B	0.87	4.84 million shs	5.01 million shs

7 Stocks That Will Be Magnificent in 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AVNS Avanos Medical	0.00%	0.00%	0.00%	+0.26%	+111.33%
CERS Cerus	+2.63%	-4.49%	-9.65%	-27.33%	+49.04%
QDEL QuidelOrtho	+12.72%	+12.10%	-13.10%	-28.59%	-59.51%
XRAY DENTSPLY SIRONA	-1.27%	-7.76%	-24.78%	-29.78%	-35.10%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AVNS Avanos Medical	1.50	Reduce	N/A	N/A
CERS Cerus	2.40	Hold	$5.25	124.36% Upside
QDEL QuidelOrtho	1.50	Reduce	$13.63	12.23% Upside
XRAY DENTSPLY SIRONA	2.00	Hold	$13.31	55.46% Upside

Current Analyst Ratings Breakdown

Latest CERS, XRAY, AVNS, and QDEL Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/17/2026	XRAY DENTSPLY SIRONA	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Market Perform	$13.00 ➝ $10.00
9/14/2026	CERS Cerus	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
8/24/2026	XRAY DENTSPLY SIRONA	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Underweight	$9.00 ➝ $11.00
8/20/2026	CERS Cerus	Freedom Broker Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$6.50
8/12/2026	QDEL QuidelOrtho	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold ➝ Strong Sell
8/10/2026	XRAY DENTSPLY SIRONA	Barrington Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$15.00
8/7/2026	XRAY DENTSPLY SIRONA	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Market Perform	$13.00
8/3/2026	XRAY DENTSPLY SIRONA	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
7/29/2026	XRAY DENTSPLY SIRONA	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Neutral	$13.00 ➝ $14.00
7/20/2026	AVNS Avanos Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
7/17/2026	QDEL QuidelOrtho	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)

(Data available from 10/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AVNS Avanos Medical	$715.90M	1.64	$3.42 per share	7.30	$16.73 per share	1.49
CERS Cerus	$206.13M	2.29	N/A	N/A	$0.34 per share	6.88
QDEL QuidelOrtho	$2.73B	0.30	$21.30 per share	0.57	$28.27 per share	0.43
XRAY DENTSPLY SIRONA	$3.68B	0.46	$5.94 per share	1.44	$6.72 per share	1.27

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AVNS Avanos Medical	-$72.90M	-$1.61	N/A	26.59	N/A	-10.39%	5.39%	3.97%	N/A
CERS Cerus	-$15.63M	-$0.03	N/A	N/A	N/A	-3.06%	-10.19%	-3.14%	11/5/2026 (Estimated)
QDEL QuidelOrtho	-$1.13B	-$15.41	N/A	8.26	N/A	-39.20%	4.88%	1.63%	11/4/2026 (Estimated)
XRAY DENTSPLY SIRONA	-$598M	-$2.75	N/A	5.71	1.10	-14.99%	20.84%	5.32%	11/5/2026 (Estimated)

Latest CERS, XRAY, AVNS, and QDEL Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/6/2026	Q2 2026	QDEL QuidelOrtho	-$0.0488	$0.13	+$0.1788	-$1.36	$618.72 million	$630.90 million
8/6/2026	Q2 2026	XRAY DENTSPLY SIRONA	$0.3480	$0.52	+$0.1720	$0.18	$889.93 million	$898.00 million
7/30/2026	Q2 2026	CERS Cerus	-$0.0133	-$0.01	+$0.0033	-$0.01	$62.90 million	$63.30 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
AVNS Avanos Medical	N/A	N/A	N/A	N/A	N/A
CERS Cerus	N/A	N/A	N/A	N/A	N/A
QDEL QuidelOrtho	N/A	N/A	N/A	N/A	N/A
XRAY DENTSPLY SIRONA	N/A	N/A	+9.86%	N/A	13 Years

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AVNS Avanos Medical	0.11	2.48	1.40
CERS Cerus	0.49	1.83	1.07
QDEL QuidelOrtho	1.43	1.39	0.76
XRAY DENTSPLY SIRONA	1.48	1.63	1.07

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AVNS Avanos Medical	95.17%
CERS Cerus	78.37%
QDEL QuidelOrtho	99.00%
XRAY DENTSPLY SIRONA	95.70%

Insider Ownership

Company	Insider Ownership
AVNS Avanos Medical	2.33%
CERS Cerus	5.30%
QDEL QuidelOrtho	1.10%
XRAY DENTSPLY SIRONA	0.46%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AVNS Avanos Medical	4,040	46.85 million	45.76 million	Optionable
CERS Cerus	345	201.52 million	190.84 million	Optionable
QDEL QuidelOrtho	6,500	68.57 million	67.82 million	Optionable
XRAY DENTSPLY SIRONA	14,000	199.35 million	198.44 million	Optionable

CERS, XRAY, AVNS, and QDEL Headlines

Recent News About These Companies

DENTSPLY SIRONA (NASDAQ:XRAY) Reaches New 1-Year Low - Here's Why

October 1, 2026 | marketbeat.com

XRAY - DENTSPLY SIRONA Inc.

September 29, 2026 | seekingalpha.com

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives Average Recommendation of "Hold" from Brokerages

September 27, 2026 | americanbankingnews.com

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Stock Rated "Hold" by Sell-Side Analysts

September 27, 2026 | marketbeat.com

Dentsply Sirona's Troubles Are Nothing To Smile About (Downgrade)

September 26, 2026 | seekingalpha.com

DENTSPLY SIRONA (NASDAQ:XRAY) Hits New 1-Year Low - Time to Sell?

September 25, 2026 | marketbeat.com

Q2 rundown: Dentsply Sirona (NASDAQ:XRAY) vs other dental equipment & technology stocks

September 25, 2026 | msn.com

Dentsply Sirona returns to profit, a medical-device win in Armistice Capital’s Healthcare Book

September 24, 2026 | cyprus-mail.comC

Dentsply Sirona stock gains 5.40 percent as earnings beat estimates

September 23, 2026 | ad-hoc-news.deA

Bank of America Corp DE Makes New Investment in DENTSPLY SIRONA Inc. $XRAY

September 23, 2026 | marketbeat.com

Dentsply Sirona: The Valuation Is Low, But The Turnaround Is Not Proven Yet

September 21, 2026 | seekingalpha.com

Squarepoint Ops LLC Sells 431,734 Shares of DENTSPLY SIRONA Inc. $XRAY

September 20, 2026 | marketbeat.com

DENTSPLY SIRONA (XRAY) Receives a Hold from J.P. Morgan

September 18, 2026 | theglobeandmail.com

DENTSPLY SIRONA (NASDAQ:XRAY) Reaches New 1-Year Low - Time to Sell?

September 18, 2026 | marketbeat.com

Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio for Now

September 17, 2026 | zacks.com

DENTSPLY SIRONA (NASDAQ:XRAY) Shares Down 3.6% - Here's What Happened

September 17, 2026 | marketbeat.com

DENTSPLY SIRONA Inc. $XRAY Stock Holdings Decreased by Amundi

September 17, 2026 | marketbeat.com

VIRGINIA RETIREMENT SYSTEMS ET Al Acquires New Holdings in DENTSPLY SIRONA Inc. $XRAY

September 11, 2026 | marketbeat.com

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 182,661 Shares of DENTSPLY SIRONA Inc. $XRAY

September 10, 2026 | marketbeat.com

XRAY's Q2 Earnings Beat Meets Steady Guidance and Margin Pressure

September 8, 2026 | zacks.com

Did Dentsply Sirona Inc. Insiders Breach their Fiduciary Duties to Shareholders?

September 7, 2026 | prnewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

CERS, XRAY, AVNS, and QDEL Company Descriptions

Avanos Medical NYSE:AVNS

$24.99 0.00 (0.00%)

As of 10/2/2026

Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

Cerus NASDAQ:CERS

$2.34 +0.06 (+2.63%)

Closing price 10/5/2026 04:00 PM Eastern

Extended Trading

$2.35 +0.01 (+0.21%)

As of 10/5/2026 07:32 PM Eastern

Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. Cerus Corporation was incorporated in 1991 and is headquartered in Concord, California.

QuidelOrtho NASDAQ:QDEL

$12.14 +1.37 (+12.72%)

Closing price 10/5/2026 04:00 PM Eastern

Extended Trading

$12.16 +0.02 (+0.16%)

As of 04:01 AM Eastern

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.

DENTSPLY SIRONA NASDAQ:XRAY

$8.56 -0.11 (-1.27%)

Closing price 10/5/2026 04:00 PM Eastern

Extended Trading

$8.69 +0.13 (+1.53%)

As of 04:00 AM Eastern

DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform. It also provides endodontic products consisting of motorized endodontic handpieces, files, sealers, irrigation needles, and other tools that support root canal procedures; restorative products, including dental ceramics, crowns, and veneers; and preventative products, such as curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers, as well as dental anesthetics, prophylaxis paste, dental sealants, and impression materials. In addition, the company offers SureSmile and Byte aligner solutions; VPro/HyperByte, a high-frequency vibration technology device; SureSmile Simulator, which creates a 3D visualization of a patient's outcome; and Byte Plus for treatment planning. Further, it provides dental implants, digital dentures, crown and bridge porcelain products, bone regenerative and restorative solutions, treatment planning software, and educational programs; dental prosthetics; urology catheters; and other health-related consumables. The company serves professional dental and consumable medical device markets through third-party distributors. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest CERS, XRAY, AVNS, and QDEL Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest CERS, XRAY, AVNS, and QDEL Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

CERS, XRAY, AVNS, and QDEL Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

CERS, XRAY, AVNS, and QDEL Company Descriptions

Avanos Medical NYSE:AVNS

Cerus NASDAQ:CERS

QuidelOrtho NASDAQ:QDEL

DENTSPLY SIRONA NASDAQ:XRAY

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest CERS, XRAY, AVNS, and QDEL Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest CERS, XRAY, AVNS, and QDEL Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

CERS, XRAY, AVNS, and QDEL Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

CERS, XRAY, AVNS, and QDEL Company Descriptions

Avanos Medical NYSE:AVNS

Cerus NASDAQ:CERS

QuidelOrtho NASDAQ:QDEL

DENTSPLY SIRONA NASDAQ:XRAY

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools